QCA Ventures
VC Fund
Cincinnati, United States
QCA Ventures is a VC fund in Cincinnati focused on Health Care and Software. Queen City Angels (QCA) is a group of experienced, accredited investors committed to accelerating the growth of early-stage businesses in the Cincinnati area and the surrounding region, via smart investments capable of producing a substantial return.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 38%
- Fund size:
- $10M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries QCA Ventures invests in
Stages QCA Ventures invests in
Countries QCA Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 10 (25%)
- Software 6 (15%)
- Biotechnology 4 (10%)
- Medical 3 (8%)
- E-Commerce 3 (8%)
Stage
- Seed 15 (38%)
- Series A 7 (18%)
- Pre-Seed 4 (10%)
- Series B 4 (10%)
- Venture - Series Unknown 3 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Murphy
Accredited Investor, Member & Mentor to Entrepreneurs
|
Accredited Investor, Member & Mentor to Entrepreneurs | Total investments: 0 | Find email | |
Dan Kincaid
Investor Member
|
Investor Member | Total investments: 0 | Find email | |
G. Scott Mindrum
Active Member
|
Active Member | Total investments: 0 | Find email | |
John Lilly
Investor Member
|
Investor Member | Total investments: 0 | Find email | |
Maria Lankenau
Ascent Member & Investor
|
Ascent Member & Investor | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BRANDRANK.AI help Brands continuously monitor and strengthen positioning using generative AI. | $3M / Seed / Jul 28, 2026 | ||
| Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform. | $25M / Series B / Dec 12, 2025 | ||
| TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems. | $3.9M / Seed / May 27, 2025 | ||
| 1Logtech provides an AI-driven self-service connectivity platform for EDI and API integrations in logistics. The solution allows operational teams, without coding expertise, to build and manage integrations with carriers, customers, TMS, ERP, and WMS systems. | $1.5M / Seed / Jan 30, 2025 | ||
| Trinity Guardion is a manufacturer of a launderable protective patient barrier for hospital beds. Our Trinity Bed Protection System™ delivers a level of cleanliness for hospital mattresses and bed decks previously unseen in the healthcare industry. | $3.5M / Series B / Oct 30, 2024 | ||
| SureImpact creates an impact management and reporting solution for social-good organizations and their funders. SureImpact elevates service coordination by assisting mission-driven professionals in moving beyond simply measuring what they did (outputs) to how individuals, families, and communities benefit (outcomes and impact). SureImpact solutionsare specifically designed for the non-profit sector to capture invaluable insights that can be used to improve their organization's delivery of mission-critical services, engage their communities, attract new sources of funding, and increase trust among their constituents. | $2M / Seed / Apr 06, 2023 | ||
| Tactile Engineering develops and manufactures affordable tactile graphics tablets for use by blind and visually impaired individuals. | $1.5M / Venture - Series Unknown / Feb 16, 2023 | ||
| C360 Technologies is a video technology that delivers quality non-stitched immersive video products to date. C360 is a different kind of 360/VR company. Unlike most, they don’t stitch or require multi-headed cameras to deliver our stunning 6K immersive broadcast and streaming video. They've worked in the industry since 2008 pioneeringoriginal 360 technologies that continue to deliver the highest quality, non-stitched immersive video in the world. Their live output for linear broadcast and OTT streaming platforms coupled with the industry's smallest pro-grade immersive camera is unique compared to others. C360 delivers multiple HD-SDI outputs directly to the broadcast backhaul for live television events while simultaneously delivering a 4K stream to the OTT platform for distribution across VR and second screen (magic screen) applications. Unlimited users are now empowered to independently control their camera location and P/T/Z during the live event.The company was founded in 2008 and is headquartered in Wexford, Pennsylvania. | Venture - Series Unknown / Oct 11, 2022 | ||
| Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform. | $3.3M / Series A / Sep 15, 2022 | ||
| Cloverleaf improves team dynamics by integrating disconnected HR data and insights into personalized, actionable development experiences at scale. Cloverleaf enables personalized coaching, clearer communication, and stronger team alignment throughout the entire employee lifecycle. Built upon validated behavioral assessments and real-timeperformance insights, Cloverleaf empowers managers and teams to collaborate effectively, resolve challenges proactively, and unlock greater human potential. Trusted by more than 30,000 teams, Cloverleaf helps organizations create cohesive, aligned teams, improving employee performance, engagement, and productivity. For more information, visit cloverleaf.me. | $9M / Series A / Jun 09, 2022 | ||
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does QCA Ventures invest in?
QCA Ventures invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Series A stage. Most of the 40 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact QCA Ventures?
Public channels for QCA Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at QCA Ventures?
The team at QCA Ventures includes Daniel Murphy (Accredited Investor, Member & Mentor to Entrepreneurs), Dan Kincaid (Investor Member) and G. Scott Mindrum (Active Member), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
